Literature DB >> 26210550

Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia.

R C Roberts1, K A Barksdale2, J K Roche2, A C Lahti2.   

Abstract

Schizophrenia (SZ) is a mental illness characterized by psychosis, negative symptoms, and cognitive deficits. The anterior cingulate cortex (ACC), a structurally and functionally diverse region, is one of several brain regions that is abnormal in SZ. The present study compared synaptic organization and mitochondrial number and morphology in postmortem ACC in SZ versus normal control (NC). Total synaptic density in the combined ACC was decreased in SZ, to 72% of normal controls (NCs), due to selective decreases in axospinous synapses, both asymmetric (excitatory) and symmetric (inhibitory). These changes were present in layers 3 and 5/6. The density of mitochondria in all axon terminals combined in SZ was decreased to 64% of NC. In layer 3, mitochondrial density was decreased only in terminals forming asymmetric synapses with spines, while in layers 5/6 mitochondrial density was decreased in terminals forming symmetric synapses with spines and dendrites. The proportion of terminals making symmetric synapses that contained mitochondria was significantly lower in SZ than in NCs, especially for symmetric axospinous synapses. The number of mitochondria per neuronal somata was decreased in the ACC in SZ compared to NCs; this finding was present in layers 5-6. The size of mitochondria in neuronal somata and throughout the neuropil was similar in SZ and NCs. Our results, though preliminary, are well supported by the literature, and support an anatomical substrate for some of the altered executive functions found in SZ.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dopamine; Electron microscopy; Glutamate; Neuropathology; Psychosis

Mesh:

Year:  2015        PMID: 26210550      PMCID: PMC4591176          DOI: 10.1016/j.schres.2015.07.016

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  117 in total

1.  Axonal mitochondrial transport and potential are correlated.

Authors:  Kyle E Miller; Michael P Sheetz
Journal:  J Cell Sci       Date:  2004-05-18       Impact factor: 5.285

Review 2.  Physiological role of N-acetylaspartate: contribution to myelinogenesis.

Authors:  Robert W Ledeen; Jianfeng Wang; Gusheng Wu; Zi-Hua Lu; Goutam Chakraborty; Markus Meyenhofer; Stephen K Tyring; Reuben Matalon
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

Review 3.  Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology.

Authors:  Alex Fornito; Murat Yücel; Brian Dean; Stephen J Wood; Christos Pantelis
Journal:  Schizophr Bull       Date:  2008-04-23       Impact factor: 9.306

4.  Synaptic targets of pyramidal neurons providing intrinsic horizontal connections in monkey prefrontal cortex.

Authors:  D S Melchitzky; S R Sesack; M L Pucak; D A Lewis
Journal:  J Comp Neurol       Date:  1998-01-12       Impact factor: 3.215

5.  Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia.

Authors:  Alice Egerton; Stefan Brugger; Marie Raffin; Gareth J Barker; David J Lythgoe; Philip K McGuire; James M Stone
Journal:  Neuropsychopharmacology       Date:  2012-07-04       Impact factor: 7.853

6.  Differential Calcium Binding Protein Immunoreactivity Distinguishes Classes of Relay Neurons in Monkey Thalamic Nuclei.

Authors:  E. G. Jones; S. H. C. Hendry
Journal:  Eur J Neurosci       Date:  1989-05       Impact factor: 3.386

7.  Morphology, distribution, and synaptic relations of somatostatin- and neuropeptide Y-immunoreactive neurons in rat and monkey neocortex.

Authors:  S H Hendry; E G Jones; P C Emson
Journal:  J Neurosci       Date:  1984-10       Impact factor: 6.167

8.  Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

Authors:  Jean Théberge; Yousef Al-Semaan; Peter C Williamson; Ravi S Menon; Richard W J Neufeld; Nagalingam Rajakumar; Betsy Schaefer; Maria Densmore; Dick J Drost
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

9.  The dopaminergic innervation of monkey prefrontal cortex: a tyrosine hydroxylase immunohistochemical study.

Authors:  D A Lewis; S L Foote; M Goldstein; J H Morrison
Journal:  Brain Res       Date:  1988-05-24       Impact factor: 3.252

10.  Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex.

Authors:  J F Smiley; S M Williams; K Szigeti; P S Goldman-Rakic
Journal:  J Comp Neurol       Date:  1992-07-15       Impact factor: 3.215

View more
  30 in total

1.  Alteration of gray matter microstructure in schizophrenia.

Authors:  Johanna Seitz; Yogesh Rathi; Amanda Lyall; Ofer Pasternak; Elisabetta C Del Re; Margaret Niznikiewicz; Paul Nestor; Larry J Seidman; Tracey L Petryshen; Raquelle I Mesholam-Gately; Joanne Wojcik; Robert W McCarley; Martha E Shenton; Inga K Koerte; Marek Kubicki
Journal:  Brain Imaging Behav       Date:  2018-02       Impact factor: 3.978

Review 2.  Postmortem studies on mitochondria in schizophrenia.

Authors:  Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2017-02-09       Impact factor: 4.939

3.  Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla.

Authors:  Allison S Brandt; Paul G Unschuld; Subechhya Pradhan; Issel Anne L Lim; Gregory Churchill; Ashley D Harris; Jun Hua; Peter B Barker; Christopher A Ross; Peter C M van Zijl; Richard A E Edden; Russell L Margolis
Journal:  Schizophr Res       Date:  2016-02-28       Impact factor: 4.939

4.  Ultrastructural evidence for glutamatergic dysregulation in schizophrenia.

Authors:  Rosalinda C Roberts; Lesley A McCollum; Kirsten E Schoonover; Samuel J Mabry; Joy K Roche; Adrienne C Lahti
Journal:  Schizophr Res       Date:  2020-01-31       Impact factor: 4.939

5.  Synaptic Proteome Alterations in the Primary Auditory Cortex of Individuals With Schizophrenia.

Authors:  Matthew L MacDonald; Megan Garver; Jason Newman; Zhe Sun; Joseph Kannarkat; Ryan Salisbury; Jill Glausier; Ying Ding; David A Lewis; Nathan Yates; Robert A Sweet
Journal:  JAMA Psychiatry       Date:  2020-01-01       Impact factor: 21.596

Review 6.  PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases.

Authors:  Zhengxin Cai; Songye Li; David Matuskey; Nabeel Nabulsi; Yiyun Huang
Journal:  Neurosci Lett       Date:  2018-07-31       Impact factor: 3.046

7.  Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology.

Authors:  Stephen W Scheff; Mubeen A Ansari; Elliott J Mufson
Journal:  Neurobiol Aging       Date:  2016-03-08       Impact factor: 4.673

8.  7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia.

Authors:  Meredith A Reid; Nouha Salibi; David M White; Timothy J Gawne; Thomas S Denney; Adrienne C Lahti
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

9.  Decoupling of Brain Temperature and Glutamate in Recent Onset of Schizophrenia: A 7T Proton Magnetic Resonance Spectroscopy Study.

Authors:  Sotirios Posporelis; Jennifer M Coughlin; Anouk Marsman; Subechhya Pradhan; Teppei Tanaka; Hongxing Wang; Mark Varvaris; Rebecca Ward; Cecilia Higgs; Jamie A Edwards; Candice N Ford; Pearl K Kim; Ashley M Lloyd; Richard A E Edden; David J Schretlen; Nicola G Cascella; Peter B Barker; Akira Sawa
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-04-21

10.  Association between structural and functional brain alterations in drug-free patients with schizophrenia: a multimodal meta-analysis.

Authors:  Xin Gao; Wenjing Zhang; Li Yao; Yuan Xiao; Lu Liu; Jieke Liu; Siyi Li; Bo Tao; Chandan Shah; Qiyong Gong; John A Sweeney; Su Lui
Journal:  J Psychiatry Neurosci       Date:  2018-03       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.